Coinbase Global, Inc. vs GeneDx Holdings Corp — how do they compare? Coinbase Global, Inc. trades at $148.63 (market cap $39.20B), while GeneDx Holdings Corp trades at $82.15 (market cap $2.44B). The key difference: Coinbase Global, Inc. is far larger — about 16.1× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| COIN | WGS | |
|---|---|---|
Market Cap | $39.20B | $2.44B |
Sector | Technology | Technology |
52-Week High | $387.27 | $167.51 |
52-Week Low | $141.09 | $34.51 |
Enterprise Value | $36.85B | $2.48B |
Signals from Pluang's Aura AI — not financial advice
COIN trades at $148.4, down 0.19% with a bearish technical signal. Recent earnings misses and a net loss in Q2 2026 highlight challenges despite revenue growth. The stock faces pressure from a sluggish crypto market, but maintains strong cash flow and a 55% analyst buy rating with a $207.20 price target.
Outlook remains mixed: strong fundamentals like positive EBITDA and cash flow support long-term potential, but near-term risks from earnings volatility and market sentiment weigh on performance. Investors should balance growth prospects against sector headwinds.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Trailing returns across standard periods
Latest headlines on both assets
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →